Biogen (BIIB) Shares Active on M&A Chatter
(Updated - August 2, 2016 2:46 PM EDT)
Biogen (NASDAQ: BIIB) shares volatile over Merck (NYSE: MRK), Allergan (NYSE: AGN)-related chatter.
UPDATE - Talks were said to be informal and in early stages.
It wasn't made clear whether other companies might be vying for Biogen, though Biogen might not be interested in a deal.
Biogen boasted a market cap of $68 billion ahead of today's trading action.